Side-by-side comparison of AI visibility scores, market position, and capabilities
TytoCare makes an FDA-cleared AI-powered telehealth examination device and platform that enables clinical-grade remote exams of the heart, lungs, ears, throat, skin, and abdomen; partners with 220+ health systems and payers;
TytoCare is a telehealth technology company founded in 2012 by Dedi Gilad and Ofer Tzadik, with headquarters in New York City and R&D operations in Israel. The company has developed an FDA-cleared handheld examination device paired with a digital platform and AI analysis engine that enables patients to conduct guided, clinical-grade medical examinations at home. The TytoCare device integrates a digital stethoscope (for heart and lung auscultation), otoscope (ear), camera (throat, skin, abdomen), and thermometer in a single compact unit. A clinician — joining via the TytoCare telehealth platform — guides the patient or a caregiver through the exam in real time, while the AI engine analyzes audio and visual data to assist with diagnosis and flag clinical findings.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.